Podcasts
Listen to the latest hemonc news from international experts
The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2020: Next questions in hematological malignancies
The Society of Hematologic Oncology (SOHO) 2020 Virtual Annual Meeting brought together global leading experts in hematological oncology who updated the community on the latest data and hot topics in the treatment and management of hematological malignancies.
The next questions session at SOHO 2020 illuminated important future considerations in many disease areas of hematological oncology as well as unmet needs in these patient populations.
In this podcast, we hear from Sagar Lonial, MD, FACP, of Winship Cancer Institute of Emory University, Atlanta, GA, Srdan Verstovsek, MD, PhD, and Loretta Nastoupil, MD of The University of Texas MD Anderson Cancer Center, Houston, TX, Amer Zeidan, MBBS, of Yale University and Yale Cancer Center, New Haven, CT, and finally John DiPersio, MD, PhD, of Washington University, St. Louis, MO, on the next questions in the treatment of patients with hematological malignancies.
Date: 25th September 2020
